Punicalagin - technical

CAS : 65995-63-3

Ref. 3D-FP33682

Informations sur le produit

• Nom: Punicalagin - technical
• Synonymes: 1,2,3,11,12,13-Hexahydroxy-5,10-Dioxo-8-[3,4,5,11,17,18,19,22,23,34,35-Undecahydroxy-8,14,26,31-Tetraoxo-9,13,25,32-Tetraoxaheptacyclo[25.8.0.02,7.015,20.021,30.024,29.028,33]Pentatriaconta-1(35),2,4,6,15,17,19,21,23,27,29,33-Dodecaen-10-Yl]-5,7,8,10-Tetrahydrodibenzo[F,H][1,4]Dioxecine-7-Carbaldehyde (Non-Preferred Name), 2,20,1,23-(Epoxy[2]propene[1,2]diyl[3]ylidene)-11H,15H-tribenzo[g,i,q][1,5,12]trioxacyclononadecin, <span class="text-smallcaps">D</span>-glucose deriv., <span class="text-smallcaps">D</span>-Glucose, cyclic 4,6-[(2S,2′S)-2,2′-(5,10-dihydro-2,3,7,8-tetrahydroxy-5,10-dioxo[1]benzopyrano[5,4,3-cde][1]benzopyran-1,6-diyl)bis[3,4,5-trihydroxybenzoate]] cyclic 2,3-[(1S)-4,4′,5,5′,6,6′-hexahydroxy[1,1′-biphenyl]-2,2′-dicarboxylate], <span class="text-smallcaps">D</span>-Glucose, cyclic 4,6-[(S,S)-2,2′-(5,10-dihydro-2,3,7,8-tetrahydroxy-5,10-dioxo[1]benzopyrano[5,4,3-cde][1]benzopyran-1,6-diyl)bis[3,4,5-trihydroxybenzoate]] cyclic 2,3-[(S)-4,4′,5,5′,6,6′-hexahydroxy[1,1′-biphenyl]-2,2′-dicarboxylate], <span class="text-smallcaps">D</span>-Glucose, cyclic 4,6-[2,2′-(5,10-dihydro-2,3,7,8-tetrahydroxy-5,10-dioxo[1]benzopyrano[5,4,3-cde][1]benzopyran-1,6-diyl)bis[3,4,5-trihydroxybenzoate]] cyclic 2,3-(4,4′,5,5′,6,6′-hexahydroxy[1,1′-biphenyl]-2,2′-dicarboxylate), [2(S),4(S,S)]-, D-Glucose, cyclic 4,6-(2,2'-(5,10-dihydro-2,3,7,8-tetrahydroxy-5,10-dioxo(1)benzopyrano(5,4,3-cde)(1)benzopyran-1,6-diyl)bis(3,4,5-trihydroxybenzoate)) cyclic 2,3-(4,4',5,5',6,6'-hexahydroxy(1,1'-biphenyl)-2,2'-dicarboxylate)-, (2(S),4(S,S))-, Dibenzo[f,h][1,4]dioxecin, <span class="text-smallcaps">D</span>-glucose deriv., Pomegranate extract, Punicalagins
• CAS: 65995-63-3

Description

Punicalagin is a natural compound isolated from pomegranate. It has been shown to inhibit the production of pro-inflammatory cytokines such as IL-1β, IL-6 and TNF-α in response to LPS stimulation in vitro. Punicalagin also has significant cytotoxicity against C. glabrata and other opportunistic fungal pathogens, with a median effective concentration (EC50) of 3.2 µg/mL and minimum inhibitory concentration (MIC) of 1.0 µg/mL. In addition, punicalagin inhibits NF-κB activation by downregulating Bcl-2 protein expression in the mitochondria, which may be due to its ability to inhibit mitochondrial functions through the response element region. Punicalagin has also been shown to suppress inflammatory bowel disease in an animal model using Hplc preparative methods.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 1,084.72 g/mol
• Formule: C₄₈H₂₈O₃₀
• Degré de pureté: Min. 95%
• Couleur/Forme: Powder